Chronic inflammation, as seen in Crohn’s disease, is a known risk factor for colorectal cancer, and this inflammatory microenvironment may provide a biological basis for the observed association between NOD2 polymorphisms and increased CRC risk. This evidence concerns the gene NOD2 and inflammation.